학술논문
Three-month tapering and discontinuation of long-term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial.
Document Type
Article
Author
Hadi Almayali, Abdullah Ali; Boers, Maarten; Hartman, Linda; Opris, Daniela; Bos, Reinhard; Kok, Marc R.; Ap Da Silva, Jose; Griep, Ed; Klaasen, Ruth; Allaart, Cornelia F.; Baudoin, Paul; Raterman, Hennie G.; Szekanecz, Zoltan; Buttgereit, Frank; Masaryk, Pavol; Lems, Willem; Smulders, Yvo; Cutolo, Maurizio; Ter Wee, Marieke M.
Source
Annals of the Rheumatic Diseases; Oct2023, Vol. 82 Issue 10, p1307-1314, 8p
Subject
Language
ISSN
00034967